PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels

Retigabine (RTG) is a first-in-class antiepileptic drug that suppresses neuronal excitability through the activation of voltage-gated KCNQ2–5 potassium channels. Retigabine binds to the pore-forming domain, causing a hyperpolarizing shift in the voltage dependence of channel activation. To elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Robin Y., Pless, Stephan A., Kurata, Harley T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2017
Materias:
PNAS Plus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692535/
https://www.ncbi.nlm.nih.gov/pubmed/29078287
http://dx.doi.org/10.1073/pnas.1705802114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692535/
https://www.ncbi.nlm.nih.gov/pubmed/29078287
http://dx.doi.org/10.1073/pnas.1705802114

Ejemplares similares